Skip to content

ACH - ACCENDRA HEALTH INC/VA/ - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

Accendra Health Inc

ACH · NYSE

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

ACHAccendra Health Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $5.69
52-wk low: $0.93
Prev close: $3.35
Mkt cap: $101.5M
Fwd P/E: 2.9x
Beta: 1.61

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$64.0M

DS
D.E. Shaw
Q2 2026 13F
$10.5M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 10, 2026

Earnings came in 46.2% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -11.4%
Forward P/E: 2.86
Market cap: $102M

Valuation

P/S0.04
P/B1.07

Quality

Operating margin-1.5%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ACH
Exchange: NYSE
Sector: HEALTHCARE
Industry: MEDICAL DISTRIBUTION
Market cap: $101.51M
Beta: 1.61

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

0.0x

P/B

1.1x

Profit margin

-11.4%

Op margin

-1.5%

ROE

-198.4%

$8.8M

position

AQ

AQR

Q2 2026 13F

$3.7M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ACH

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.19-46.2%

-$0.13 expected

Next report

What the street expects next

ROE

-198.4%

ROA0.6%

Growth

Beta1.61